| Merck (Schweiz) AG - Bavencio 200 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 66380 | | 01 | | Bavencio 200 mg/10 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FF04 | | | | 05.09.2017 | | |
|
| Composition |
| avelumabum 200 mg, mannitolum, acidum aceticum glaciale, polysorbatum 20, natrii hydroxidum corresp. natrium 1.725 mg, aqua ad iniectabile q.s. ad solutionem pro 10 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Avelumabum | 200mg / 10ml |
| | BAG: Active Agent | Dose |
|---|
| Avelumabum | 200 mg |
| | | | Inactive agents |
|---|
| Acidum Aceticum Glaciale | | Mannitol | | Sodium Hydroxide | | Polysorbatum 20 |
| |
|
|
